Anakinra for rheumatoid arthritis: A modest benefit with some risk

Jan 21, 2009

New research supports a modest beneficial effect of anakinra for rheumatoid arthritis patients, but warns against potential risks for serious infections and its use with other biologic medications.

Rheumatoid arthritis is a chronic inflammatory disease affecting as many as one in 100 people worldwide. It affects the joints, making them stiff and painful. Anakinra is one of a new breed of arthritis drugs licensed in the past decade called 'biologics'. The drug is the first to target the immune protein IL-1, thought to be partly responsible for inflammation in arthritis patients. It is given by daily injection.

In a Cochrane Systematic Review of five recent anakinra trials involving 2,876 patients, researchers found anakinra reduced pain and stiffness in patients, and helped to improve joint function, when compared to placebo. However, while around a quarter of patients experienced improvement in their symptoms as a result of taking anakinra, the researchers say the improvements are notably less than those seen with other biologics.

In addition, there were more injection site reactions with the use of anakinra and the rate of serious infections with anakinra was approaching statistical significance when compared to placebo. "We would recommend caution with the use of anakinra for rheumatoid arthritis, especially with the only modest beneficial outcomes compared to other biologic medications studied for rheumatoid arthritis," said lead researcher Dr. Marty Mertens of the University of Minnesota in the US.

One study included in the review investigated the combination of anakinra with another biologic medication, etanercept. This found no benefits in arthritis outcomes, but did show a significant increase in the number of serious adverse events. "On the basis of these results, we recommend that doctors avoid combining biologic medications with anakinra when treating patients with rheumatoid arthritis,' said Mertens.

Dr. Mertens thinks more research is required to better inform patients and doctors about the safety of the drug: "We have only limited data on the safety of anakinra, and need more long-term studies to evaluate this, especially the potential for increased risk of serious infections."

Source: Wiley

Explore further: Sierra Leone Ebola burial teams dump bodies in street

add to favorites email to friend print save as pdf

Related Stories

The unknown crocodiles

13 minutes ago

Just a few years ago, crocodilians – crocodiles, alligators and their less-known relatives – were mostly thought of as slow, lazy, and outright stupid animals. You may have thought something like that ...

Cohesin molecule safeguards cell division

27 minutes ago

The cohesin molecule ensures the proper distribution of DNA during cell division. Scientists at the Research Institute of Molecular Pathology (IMP) in Vienna can now prove the concept of its carabiner-like ...

Erosion may trigger earthquakes

28 minutes ago

Researchers from laboratories at Géosciences Rennes (CNRS/Université de Rennes 1), Géosciences Montpellier (CNRS/Université de Montpellier 2) and Institut de Physique du Globe de Paris (CNRS/IPGP/Université Paris Diderot), ...

Laser scanning accurately 'weighs' trees

28 minutes ago

A terrestrial laser scanning technique that allows the structure of vegetation to be 3D-mapped to the millimetre is more accurate in determining the biomass of trees and carbon stocks in forests than current ...

3Qs: Game theory and global climate talks

30 minutes ago

Last week, China and the United States announced an ambitious climate agreement aimed at reducing carbon emissions in both countries, a pledge that marks the first time that China has agreed to stop its growing emissions. ...

Recommended for you

Ebola isolation at US base 'pretty much vacation'

11 minutes ago

With plenty of flat screen TVs, game nights and even an outdoor fire pit, life in isolation for members of the U.S. military who have returned from the Ebola mission in West Africa can look a lot like summer camp.

Chinese-built Ebola center dedicated in Liberia

3 hours ago

China, one of the first countries to send aid to battle Ebola in West Africa, ramped up the assistance significantly Tuesday by opening a 100-bed treatment center in Liberia as rows of uniformed Chinese army ...

Superbug in SE Michigan shows recent decline

6 hours ago

A new study finds a decrease in an emergent strain of methicillin-resistant S. aureus (MRSA) that is resistant to last line defense antibiotics. Researchers examined the prevalence of vancomycin-resistant Staphylococcus aureus (V ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.